Impact of relatively new chemotherapeutic agents on the outcome of Egyptian patients with advanced malignant pleural mesothelioma
Purpose: Patients with malignant pleural mesothelioma (MPM) are well known to have poor response to chemotherapy. The aim of this work was to evaluate the efficacy and safety of new chemotherapeutic agents for the treatment of Egyptian MPM patients.
Main Authors: | Gaafar R, Khaled H, Sallam Y.A., Shafik H, Aboulkassem F.A., Emara M |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2014-08-01
|
Series: | Forum of Clinical Oncology |
Subjects: | |
Online Access: | https://doi.org/10.2478/fco-2014-0005 |
Similar Items
-
Modern management of malignant pleural mesothelioma
by: Patel SC, et al.
Published: (2016-05-01) -
Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II study
by: Takaya Ikeda, et al.
Published: (2020-07-01) -
European guidelines for the management of malignant pleural mesothelioma
by: Eric van Thiel, et al.
Published: (2011-10-01) -
Long term survival after trimodal therapy in malignant pleural mesothelioma
by: René Fahrner, et al.
Published: (2012-10-01) -
Malignant pleural mesothelioma
by: Rao Sukhesh
Published: (2009-01-01)